Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Dr
Recombinant HGF was treated only with LASSS (at the same 1:8000 molar ratio to HGF as described earlier, without exposure to peroxynitrire) and then applied to centrifugal ultra-filtration (10-kDa MWCO) to thoroughly wash out un-reacted, free LASSS (FW: 238.39) prior to the c-met binding assay
When contamination is adequately controlled, non-Lactobacillus-dominant profiles have been associated with increased risk of implantation failure and may contribute to the inflammatory endometrial phenotypes observed in a subset of RIF and RM patients [380]
PMC 5998102
The table below outlines out-of-pocket expenses by drug tier
Availability is phased: it is rolling out on private prescription during the second half of 2026 and is not yet available on the NHS
US$ 26.07
US$ 23.25
US$ 25.69
US$ 22.93
US$ 26.22
US$ 20.39
US$ 22.71
US$ 26.41
US$ 22.13
US$ 21.17
